Six months after scoring FDA approval for hemophilia B gene therapy Beqvez, Pf | For the second time in six months, the FDA ...

AstraZeneca has bagged a cardiovascular disease candidate from China's CSPC Pharma in a deal potentially worth $2 billion.

The survey suggests ads can improve health management. Almost half of patients said ads help them make informed decisions ...

Lilly has earmarked $200 million for the upgrade, a company spokesperson confirmed to Fierce Pharma. The new project will ...

Thermo Fisher Scientific is responsible for helping to produce some of the hottest drugs on the market, including Novo ...

With reports swirling about potential interest in Sanofi’s consumer health business, the French pharma has confirmed that a ...

A new campaign from Opella, Sanofi’s consumer health unit, is a royal flush. | A new campaign from Opella, Sanofi’s consumer ...

The neuroscience sector has seen a surge in investment over the past year, leading to breakthroughs and high-stakes dea | ...

As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...

Two years after raiding the offices of Novartis, Switzerland’s Competition Commission (COMCO) has dropped its investigation ...

A year after Pinterest first began allowing advertisements from prescription drugmakers and prescribers, Publicis Health Media has accumulated several tips and tricks for pharmas seeking success on ...

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...